Merck Stock News

The Global "Cancer Cachexia Market" 2021-2024 research report is a professional and in-depth study on the current state of the Cancer Cachexia industry. It provides key analysis on the market status of the Cancer Cachexia manufacturers with best-in-class facts and

Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players

Animal Parasiticides Market research report is a complete overview of the market, covering various aspects like the product definition, segmentation based on various parameters, and the prevailing vendor landscape. the industry is anticipated to witness higher growth during the forecast

NEW DELHI, India: The Merck drug, Molnupiravir, an antiviral pill that treats mild-to-moderate COVID-19 cases, could be given emergency authorization use "within days" in India, according to Dr. Ram Vishwakarma, Chairman of the Covid Strategy Group, as quoted by New Delhi TV. He added that the drug is for use by adults who are at risk of severe COVID-19 or hospitalization. Another Covid pill developed by

Newbridge Financial Services Group Inc. grew its position in shares of Merck & Co., Inc. (NYSE:MRK) by 14.3% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,629 shares of the companys stock after acquiring an additional 204 shares during the period. Newbridge Financial Services Group Inc.s holdings in Merck & Co., Inc. were worth []

Indiana Trust & Investment Management CO boosted its holdings in Merck & Co., Inc. (NYSE:MRK) by 3.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 4,902 shares of the companys stock after buying an additional 153 shares during the period. Indiana Trust & Investment Management COs holdings []

Vaccines still remain the best way to control the pandemic, experts say. But for those who dont benefit from vaccines, or whose protection wanes, the new medicines from Merck and Pfizer will save lives.

That two different classes of antiviral have succeeded - one interrupting RNA replication, the other gumming up an essential protease - is tremendous news.

The drug Molnupriravir, a broad spectrum antiviral, has shown promise in international trials in halting the progression of Covid in its early stages.